Does VORAPAXAR Cause Dyspnoea? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Dyspnoea have been filed in association with VORAPAXAR. This represents 3.2% of all adverse event reports for VORAPAXAR.
6
Reports of Dyspnoea with VORAPAXAR
3.2%
of all VORAPAXAR reports
0
Deaths
4
Hospitalizations
How Dangerous Is Dyspnoea From VORAPAXAR?
Of the 6 reports, 4 (66.7%) required hospitalization.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VORAPAXAR. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does VORAPAXAR Cause?
Gastrointestinal haemorrhage (15)
Epistaxis (11)
Chest pain (8)
Death (8)
Drug dose omission (8)
Haemorrhage (7)
Haemoglobin decreased (5)
Malaise (5)
Rash (5)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which VORAPAXAR Alternatives Have Lower Dyspnoea Risk?
VORAPAXAR vs VORASIDENIB
VORAPAXAR vs VORETIGENE NEPARVOVEC-RZYL
VORAPAXAR vs VORICONAZOLE
VORAPAXAR vs VORINOSTAT
VORAPAXAR vs VORTIOXETINE